Several recent studies have shown that the
5-HT1A agonist indorenate possesses antianxiety properties. In the present study we report on other behavioural actions of this
drug.
Indorenate (31.6 mg/kg) induced flat body posture, forepaw treading and hind limb abduction, behavioural characteristics of the
serotonin syndrome. After
indorenate injection these same behaviours were observed in animals pretreated with
p-chlorophenylalanine (400 mg/kg X 3 days), suggesting that the action of this compound is not mediated via
serotonin release. The beta-5-HT1 blockers, (-)
pindolol (2 mg/kg) or (-)
alprenolol (5 mg/kg), did not prevent the actions of
indorenate on the
serotonin syndrome.
Indorenate (10 mg/kg) stimulated the masculine sexual behaviour by reducing the number of intromissions preceding ejaculation. Higher doses (17.8 mg/kg) cause a complete inhibition of sexual behaviour. (-)
Pindolol (2 mg/kg) or (-)
alprenolol (5 mg/kg) did not antagonize the facilitatory actions of
indorenate on male sexual behaviour. A high dose of
indorenate (31.6 mg/kg) resulted in an impairment of the motor coordination as tested in a treadmill apparatus. These data reveal that
indorenate possesses, in addition to its
antianxiety effects, other behavioural characteristics that, however, appear at higher dose levels.